Jordan Strom, M.D.
Division of Cardiovascular Medicine
Medical School: Harvard Medical School, 2011
Internship/Residency: Massachusetts General Hospital, 2014
Certifications: American Board of Internal Medicine
Dr. Jordan Strom is Instructor in Medicine at Harvard Medical School and a non-invasive cardiologist, specializing in echocardiography and cardiovascular magnetic resonance at Beth Israel Deaconess Medical Center and Harvard Medical School. He received his B.S. in Biology from Yale University and an M.D. from Harvard Medical School. He trained in Internal Medicine at the Massachusetts General Hospital and in Cardiovascular Medicine at Beth Israel Deaconess Medical Center where he was Chief Fellow for the 2017-2018 year. He has received additional post-graduate training in Clinical Epidemiology and Biostatistics at the Harvard T.H. Chan School of Public Health where he is expected to receive a M.Sc. in Epidemiology in May 2018.
Dr. Strom was the inaugural fellow and is a current faculty investigator at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. His research involves evaluation of the impact of public policies and care structures pertaining to cardiovascular disease on health outcomes. In particular, he specializes in the use of large administrative, registry, and clinical trial data to refine prediction for a variety of cardiovascular disease states, especially valvular heart disease, and in evaluating trends and comparative effectiveness of cardiovascular therapies. He is currently an ad hoc reviewer for the Journal of Cardiac Magnetic Resonance (JCMR) and Assistant Reviewer for the journal Circulation: Cardiovascular Quality and Outcome.
His methodological expertise spans epidemiologic and biostatistical methods, including advanced statistical regression, longitudinal analysis, supervised and unsupervised machine learning techniques, survival analysis, decision analysis, and advanced prediction modeling. He is also interested in using translational techniques such as molecular phenotyping with metabolite or proteomic profiling to discriminate risk and benefit among cardiovascular disease patients. He has expertise in prediction of cardiac diseases states, comparative effectiveness research, large database analysis, epidemiologic study design, and use of validated patient-reported outcome measures.
375 Longwood Avenue, 4th Boston, MA 02215